Gemma Holtby
- Gemma Holby: A Former Nurse Living with a Rare Disease
- Diagnosis and Symptoms
- Losing Her Strength
- Trigger Factors and Impact
- Family Support and Advocacy
- Research and Testing
- Personal Reflections
Gemma Holby: A Former Nurse Living with a Rare Disease
Gemma Holby, a former nurse from Harlow, Essex, suffers from a rare condition called very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency. The disease prevents her body from breaking down certain fats, which attacks her muscles when she exercises or experiences stress.

Diagnosis and Symptoms
Holby's condition was first diagnosed in 2012 after she noticed that her urine had turned black. This discoloration is a telltale sign of muscle breakdown. Doctors informed her that she would need to take medication for the rest of her life and use a mobility scooter. She also follows a strict low-fat, high-carbohydrate diet to manage the debilitating pain caused by her condition.

Losing Her Strength
Prior to her diagnosis, Holby was very active, working as a nurse and caring for her young children. However, her disease has drastically changed her life. She now spends most of her time resting, unable to engage in the activities she once loved. The transition from being highly mobile to virtually bedbound has been emotionally challenging.

Trigger Factors and Impact
VLCAD deficiency worsens with stress and physical exertion. Holby's muscles are constantly under attack because her body cannot properly convert fats. This causes intense pain, similar to severe cramps. Even everyday activities, such as talking to her children, can be difficult on particularly bad days.

Family Support and Advocacy
Holby's husband, Adam, is her primary caregiver. Her family provides tremendous support, helping her through the toughest moments. She is determined to raise awareness about metabolic diseases and is actively involved in establishing The Metabolic Foundation.
Research and Testing
The condition is caused by a mutated gene, which Holby inherited from both her parents. It affects approximately 1 in 140,000 people. Holby's son, Liam, is also a carrier of the VLCAD mutation, exhibiting milder symptoms. She hopes to advocate for early testing programs to diagnose carriers and prevent life-threatening complications.
Personal Reflections
Holby's confidence has been impacted by her disease, but her work with The Metabolic Foundation has provided her with a sense of purpose. She hopes to continue providing care to others, similar to the support she offered as a nurse. The foundation aims to raise awareness and help families affected by rare genetic disorders like VLCAD deficiency.
Great Britain




